The Platform
An Integrated Cognitive Health Platform
Aerobics for Eyes is developing two complementary products built on decades of applied research and legacy intellectual property — designed for scalable SaaS delivery across healthcare, insurance, government, and consumer markets.
— Platform Overview
Two Products. One Mission.
VMdetect and VMaerobics are designed to work together as a complete cognitive health solution — from rapid early detection to measurable long-term improvement.
Step 1
VMdetect™
Rapid web-based cognitive screening identifies individuals at risk — quickly, affordably, and without clinical infrastructure.
Step 2
VMaerobics™
Targeted 3D cognitive training improves the specific deficits identified by VMdetect, with measurable, trackable outcomes.
— VMdetect™
VMdetect™
Target Launch: 2025Rapid Web-Based Cognitive Screening
VMdetect is a 5-minute, IRB-exempt web-based screening procedure that measures Vision Processing Speed (VPS) — a validated early biomarker of cognitive decline.
5-Minute Screening
Designed for rapid administration in any setting — clinical, institutional, or consumer — without specialized equipment or trained staff.
Any Device, Any Location
Operable on any internet-connected device. No app download, no hardware, no lab required.
Immediate Results
Results are delivered instantly, enabling real-time clinical decision support and population-level monitoring.
IRB-Exempt Protocol
The screening procedure is designed to meet IRB-exempt criteria, reducing regulatory burden for institutional deployment.
Clinical Applications
- Early detection of dementia and Alzheimer's disease
- Post-stroke and traumatic brain injury monitoring
- Autism spectrum cognitive assessment
- Pilot and driver fitness-for-duty evaluation
- Athlete concussion baseline and return-to-play screening
- Reading deficiency identification in educational settings
— VMaerobics™
VMaerobics™
Target Launch: 2027Cognitive Training & Performance Program
VMaerobics is a 10-minute, 3D web-based cognitive training program built on the patented original Aerobics for Eyes methodology (U.S. Patent, 1991) — validated against the findings of the landmark ACTIVE Study.
Patented 3D Methodology
Built on the original AfE patent (U.S. Patent, 1991), VMaerobics uses three-dimensional visual stimuli to engage and strengthen cognitive processing pathways.
10-Minute Daily Sessions
Short, structured sessions designed for consistent daily use — maximizing adherence and long-term cognitive benefit.
Measurable Outcomes
Improves Vision Processing Speed, working memory, and executive decision-making — with trackable progress over time.
ACTIVE Study Alignment
Training outcomes are consistent with the landmark ACTIVE Study (JAMA, 2002), which demonstrated 87% improvement in VPS and reversal of 7–14 years of cognitive decline.
Target Markets
- Healthcare systems and hospital networks
- Insurance carriers and managed care organizations
- Government agencies (VA, DOT, Air Force)
- Corporate wellness and employee health programs
- Consumer direct-to-patient subscription
- Educational institutions and school districts
— Intellectual Property
Legacy IP & Proprietary Methodology
The platform is built on a foundation of proprietary intellectual property developed over three decades of applied research.
U.S. Patent (1991)
The original Aerobics for Eyes methodology is protected by a U.S. patent covering the 3D visual cognitive training approach.
VMdetect™ Trademark
VMdetect is a registered trademark of Aerobics for Eyes, LLC.
VMaerobics™ Trademark
VMaerobics is a registered trademark of Aerobics for Eyes, LLC.
Proprietary Screening Protocol
The VMdetect screening procedure incorporates proprietary algorithms and normative data developed through internal clinical studies.
— Development Roadmap
Development Timeline
2024–2025
VMdetect Development & Launch
- Complete VMdetect web platform development
- Pilot deployment with clinical partners
- Commercial launch of VMdetect SaaS product
2025–2026
Market Expansion
- Healthcare system and insurance carrier partnerships
- Government agency deployment (VA, DOT)
- Consumer subscription launch
2026–2027
VMaerobics Development & Launch
- Complete VMaerobics 3D training platform development
- Integrated VMdetect + VMaerobics platform launch
- International market expansion
Ready to Learn More?
We welcome inquiries from investors, clinical partners, and research collaborators.